RT Journal Article
SR Electronic
T1 COVID-19 Vaccine: Newspaper Coverage of the side effects of the vaccine in Nigeria
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.02.21264454
DO 10.1101/2021.10.02.21264454
A1 Soyemi Kehinde Victor
A1 Olagoke Ewedairo
A1 Charles Olomofe
YR 2021
UL http://medrxiv.org/content/early/2021/10/04/2021.10.02.21264454.abstract
AB Background COVID-19 Vaccine hesitancy is increasing globally, and this threatens the world’s ability to bring the pandemic under control. The way the media reports on the vaccine may influence or affect how the population perceive the safety and efficacy of the vaccine.Methods The aim of this study was to determine how newspapers in Nigeria report stories about the vaccine and the side effects of the vaccine amidst the growing fear on the safety of the vaccine. A total of 4 national daily newspapers were randomly selected for the study. These are Leadership, Guardian, Nation and Punch newspapers. The study was anchored on agenda setting theory. Quantitative content analysis research was used for the study. The duration of the study was the day the vaccine was introduced in Nigeria: March 1st, 2021 to July 31st, 2021. An Excel sheet served as the instrument for data collection and analysis done using SPSS version 25 with the level of significance predetermined at a p-value <0.05.Results Key findings from this research were: Government officials and technical experts were predominantly used by the newspapers as the source of their information. There was a mixed reporting of vaccine side effects with a significant difference between those newspaper publications that reported vaccine side effects and those that didn’t. Amongst those that reported side effects, there was also a significant difference between those that communicated how and where to report the side effects as against those that didn’t.Conclusion As part of the effort to curtail vaccine hesitancy, a continuous improvement in communicating the vaccine efficacy and safety is needed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe received no funding for this workAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Nil ethical approval neededAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAvailability of Data and Materials The data used and or analysed in this study is available on request from the corresponding author on reasonable request.